The minimally important difference for patient-reported outcomes in spondyloarthropathies including pain, fatigue, sleep, and Health Assessment Questionnaire

The Journal of Rheumatology
Laura Wheaton, Janet Pope

Abstract

To study minimal important differences (MID) in spondyloarthropathies (SpA). MID are important in determining clinically relevant changes and for interpretation of trials and treating patients. MID have been widely studied in rheumatoid arthritis, but less so in SpA. Patients with SpA had to be seen for 2 consecutive visits and have completed the Health Assessment Questionnaire (HAQ) and 100 mm visual analog scale on both visits for fatigue, pain, sleep, and global assessment. At the second visit they had to answer a question regarding any change in their overall health (from last visit), responding with much better, better, same, worse, or much worse. The MID were the mean changes for those who were either better or worse. Our study involved 140 eligible patients with a SpA: 69% were men, the mean age was 45 years, and the mean disease duration was 14.5 years. Almost half the patients rated themselves as unchanged from the previous visit but the remainder were either better or worse, with a minority rating themselves as much better or much worse. The MID for better and worse outcomes were HAQ (-0.136; 0.220), pain (-6.93; 18.97), fatigue (-1.43; 14.42), and sleep (-2.23; 10.76). No gender differences were observed. Our results...Continue Reading

References

Sep 1, 1979·Clinical Orthopaedics and Related Research·S Forouzesh, R Bluestone
Dec 1, 1989·Controlled Clinical Trials·R JaeschkeG H Guyatt
Feb 1, 1980·Arthritis and Rheumatism·J F FriesH R Holman
Jun 10, 2003·Arthritis and Rheumatism·Frederick WolfeHyon K Choi
Jun 19, 2003·Journal of Clinical Epidemiology·Ross D CrosbyG Rhys Williams
Sep 18, 2003·Rheumatology·E Dernis-LabousM Dougados
Feb 11, 2004·Current Opinion in Rheumatology·Michael M Ward
Sep 11, 2004·Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses·Tone RustøenChristine Miaskowski
Apr 27, 2005·Evaluation & the Health Professions·Ron D HaysKa-Kit Hui
Oct 7, 2005·Arthritis and Rheumatism·Michael M WardJohn D Reveille
Apr 6, 2006·Rheumatology·J MartindaleJ A Goodacre
Sep 2, 2006·Arthritis and Rheumatism·Daniel AletahaMichael M Ward
Jan 26, 2007·Rheumatology International·Yasemin TuranAlev Gurgan

❮ Previous
Next ❯

Citations

Aug 26, 2014·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Soili AlanneHarri Sintonen
Jul 9, 2016·BMC Medical Research Methodology·Åsa NordinAnna Dencker
Jun 17, 2006·Best Practice & Research. Clinical Rheumatology·Jane ZochlingDésirée van der Heijde
Apr 17, 2015·Journal of Attention Disorders·Yoko TanakaHimanshu Upadhyaya
Nov 28, 2018·Investigative Ophthalmology & Visual Science·Masahiko AyakiKazuno Negishi
Aug 1, 2012·American Journal of Audiology·Ilya AdamchicPeter Alexander Tass
Oct 23, 2020·Arthritis Care & Research·Chris Y LaneLouise M Thoma

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.